News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
659,645 Results
Type
Article (54052)
Company Profile (197)
Press Release (605387)
Multimedia
Podcasts (123)
Webinars (15)
Section
Business (179994)
Career Advice (2738)
Deals (33206)
Drug Delivery (130)
Drug Development (79375)
Employer Resources (167)
FDA (16751)
Job Trends (15308)
News (318162)
Policy (32573)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2856)
Accelerated approval (34)
Adcomms (35)
Allergies (146)
Alliances (46576)
ALS (173)
Alzheimer's disease (1719)
Antibody-drug conjugate (ADC) (331)
Approvals (16939)
Artificial intelligence (536)
Autoimmune disease (161)
Automation (38)
Bankruptcy (342)
Best Places to Work (11575)
BIOSECURE Act (19)
Biosimilars (203)
Biotechnology (133)
Bladder cancer (162)
Brain cancer (64)
Breast cancer (657)
Cancer (4885)
Cardiovascular disease (439)
Career advice (2328)
Career pathing (40)
CAR-T (296)
CDC (56)
Celiac Disease (2)
Cell therapy (779)
Cervical cancer (34)
Clinical research (68044)
Collaboration (1766)
Company closure (5)
Compensation (536)
Complete response letters (72)
COVID-19 (2952)
CRISPR (94)
C-suite (842)
Cystic fibrosis (149)
Data (6170)
Decentralized trials (2)
Denatured (27)
Depression (145)
Diabetes (520)
Diagnostics (6731)
Digital health (42)
Diversity (7)
Diversity, equity & inclusion (39)
Drug discovery (250)
Drug pricing (211)
Drug shortages (32)
Duchenne muscular dystrophy (236)
Earnings (70300)
Editorial (64)
Employer branding (22)
Employer resources (151)
Events (90272)
Executive appointments (992)
FDA (19880)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (10)
Frontotemporal dementia (22)
Funding (1489)
Gene editing (206)
Generative AI (48)
Gene therapy (636)
GLP-1 (1095)
Government (5021)
Grass and pollen (8)
Guidances (384)
Healthcare (18794)
HIV (62)
Huntington's disease (48)
IgA nephropathy (85)
Immunology and inflammation (276)
Immuno-oncology (57)
Indications (100)
Infectious disease (3232)
Inflammatory bowel disease (190)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (243)
Interviews (513)
IPO (14843)
IRA (51)
Job creations (4044)
Job search strategy (1916)
JPM (68)
Kidney cancer (16)
Labor market (77)
Layoffs (632)
Leadership (39)
Legal (7394)
Liver cancer (98)
Longevity (15)
Lung cancer (663)
Lymphoma (375)
Machine learning (42)
Management (60)
Manufacturing (798)
MASH (166)
Medical device (13651)
Medtech (13699)
Mergers & acquisitions (19344)
Metabolic disorders (1358)
Multiple sclerosis (162)
NASH (21)
Neurodegenerative disease (347)
Neuropsychiatric disorders (94)
Neuroscience (2997)
Neurotech (1)
NextGen: Class of 2026 (6773)
Non-profit (4883)
Now hiring (55)
Obesity (660)
Opinion (303)
Ovarian cancer (164)
Pain (210)
Pancreatic cancer (223)
Parkinson's disease (294)
Partnered (33)
Patents (469)
Patient recruitment (482)
Peanut (59)
People (55993)
Pharmaceutical (32)
Pharmacy benefit managers (32)
Phase 1 (21175)
Phase 2 (29709)
Phase 3 (22739)
Pipeline (5126)
Policy (315)
Postmarket research (2564)
Preclinical (8267)
Press Release (63)
Prostate cancer (245)
Psychedelics (52)
Radiopharmaceuticals (265)
Rare diseases (884)
Real estate (5741)
Recruiting (73)
Regulatory (24695)
Reports (40)
Research institute (2577)
Resumes & cover letters (416)
Rett syndrome (28)
RNA editing (16)
RSV (83)
Schizophrenia (152)
Series A (250)
Series B (192)
Service/supplier (8)
Sickle cell disease (101)
Special edition (23)
Spinal muscular atrophy (168)
Sponsored (37)
Startups (3609)
State (1)
Stomach cancer (19)
Supply chain (108)
Tariffs (96)
The Weekly (94)
Vaccines (1117)
Venture capital (96)
Weight loss (451)
Women's health (82)
Worklife (22)
Date
Last 7 days (545)
Last 30 days (1928)
Last 365 days (28367)
2026 (2739)
2025 (28775)
2024 (33100)
2023 (37851)
2022 (48512)
2021 (52915)
2020 (52612)
2019 (46527)
2018 (35746)
2017 (32332)
2016 (31354)
2015 (35444)
2014 (27092)
2013 (22258)
2012 (24030)
2011 (24808)
2010 (22083)
Location
Africa (946)
Alabama (85)
Alaska (7)
Arizona (244)
Arkansas (14)
Asia (39322)
Australia (6773)
California (10696)
Canada (2845)
China (1073)
Colorado (461)
Connecticut (442)
Delaware (280)
Europe (90691)
Florida (1493)
Georgia (325)
Hawaii (4)
Idaho (62)
Illinois (827)
India (64)
Indiana (501)
Iowa (21)
Japan (403)
Kansas (117)
Kentucky (41)
Louisiana (25)
Maine (80)
Maryland (1275)
Massachusetts (6900)
Michigan (310)
Minnesota (564)
Mississippi (6)
Missouri (131)
Montana (29)
Nebraska (28)
Nevada (118)
New Hampshire (84)
New Jersey (2695)
New Mexico (31)
New York (2719)
North Carolina (1338)
North Dakota (10)
Northern California (5120)
Ohio (301)
Oklahoma (21)
Oregon (41)
Pennsylvania (1982)
Puerto Rico (22)
Rhode Island (44)
South America (1293)
South Carolina (62)
South Dakota (1)
Southern California (4257)
Tennessee (168)
Texas (1572)
United States (36456)
Utah (347)
Vermont (1)
Virginia (253)
Washington D.C. (78)
Washington State (860)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
659,645 Results for "pierre fabre sa".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pierre Fabre Laboratories and Iktos Announce an Integrated AI-Driven Drug Discovery Collaboration in Oncology
January 9, 2026
·
6 min read
Press Releases
PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION
January 12, 2026
·
4 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Updated Phase 3 Tabelecleucel Data at American Society of Hematology Meeting in Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
December 8, 2025
·
7 min read
Press Releases
Pierre Fabre Laboratories Announces Global Partnership with Know Your Lemons Foundation for Breast Cancer Awareness Month
September 30, 2025
·
2 min read
Press Releases
Pierre Fabre Pharmaceuticals Announces Transfer from Atara Biotherapeutics of the Biologics License Application (BLA) for Tabelecleucel as Treatment of Epstein-Barr Virus Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD)
November 3, 2025
·
5 min read
Press Releases
Pierre Fabre Pharmaceuticals, Inc. Announces Transfer of Investigational New Drug Application for Tabelecleucel from Atara Biotherapeutics, Inc.
July 16, 2025
·
5 min read
Press Releases
Pierre Fabre USA Unites with Breast Cancer Alliance to Advance Breast Cancer Surgery
May 20, 2025
·
5 min read
Press Releases
Pierre Fabre Laboratories Strengthen R&D Portfolio and Announce the Acquisition of the Worldwide Rights for PFL-721 and PFL-241
June 16, 2025
·
2 min read
Business
Kinnate Biopharma Inc. Sells Its Investigational Pan-RAF Inhibitor, Exarafenib, to Pierre Fabre Laboratories
Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate” or the “Company”), a clinical-stage precision oncology company, and Pierre Fabre Médicament, SAS (“Pierre Fabre Laboratories”), a global player in oncology, today announced their agreement to the sale of the Company’s investigational pan-RAF inhibitor, exarafenib, and other pan-RAF program assets pursuant to the APA entered into by the parties.
March 1, 2024
·
10 min read
Press Releases
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
March 12, 2025
·
2 min read
1 of 65,965
Next
